Sequence information
Variant position: 392 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 457 The length of the canonical sequence.
Location on the sequence:
MKLSFRARAYGFRGPGPQLR
R GWRPSSREDSLEAGLPLQVR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MKLSFRARAYGFRGPGPQLRR GWRPSSREDSLEAGLPLQVR
Mouse MKLSFRTRAYGFRDPGPQLRR GWRPSSREDSVEA------R
Rat MKLSFRARAYGFRDPGPQLRR GWRPSSREDSVEA------R
Bovine MRLSFRARGYGFRGPGLQLRR GWRPNSREDSVEAGLPLQVR
Horse MKLSFRARAYGFRGPGLQLRR GWRPSSREDSIEAGLPPPVR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Literature citations
The catecholamine release-inhibitory 'catestatin' fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses.
Mahata S.K.; Mahata M.; Wen G.; Wong W.B.; Mahapatra N.R.; Hamilton B.A.; O'Connor D.T.;
Mol. Pharmacol. 66:1180-1191(2004)
Cited for: VARIANTS SER-382; LEU-388 AND GLN-392; CHARACTERIZATION OF VARIANTS SER-382; LEU-388 AND GLN-392; FUNCTION (CATESTATIN);
Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.
Biswas N.; Vaingankar S.M.; Mahata M.; Das M.; Gayen J.R.; Taupenot L.; Torpey J.W.; O'Connor D.T.; Mahata S.K.;
Endocrinology 149:749-757(2008)
Cited for: VARIANTS SER-382; LEU-388 AND GLN-392; CHARACTERIZATION OF VARIANTS SER-382; LEU-388 AND GLN-392; PROTEOLYTIC PROCESSING;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.